Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0F5JR
|
||||
Former ID |
DIB005036
|
||||
Drug Name |
ONO-1603
|
||||
Synonyms |
N-(4-Chlorobenzyl)-4-[2(S)-formylpyrrolidin-1-yl]-4-oxobutyramide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cognitive disorders [ICD9: 290-294, 294.0, 780.09, 780.9, 780.93; ICD10:F01-F07, F04, F05, R41.3] | Phase 2 | [545099] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H19ClN2O4
|
||||
Canonical SMILES |
OC(=O)[C@@H]1CCCN1C(=O)CCC(=O)NCc2ccc(Cl)cc2
|
||||
InChI |
1S/C16H19ClN2O4/c17-12-5-3-11(4-6-12)10-18-14(20)7-8-15(21)19-9-1-2-13(19)16(22)23/h3-6,13H,1-2,7-10H2,(H,18,20)(H,22,23)/t13-/m0/s1
|
||||
InChIKey |
CYDZCFWTMBKLOW-ZDUSSCGKSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Prolyl endopeptidase | Target Info | Modulator | [534253] | |
KEGG Pathway | Renin-angiotensin system | ||||
PANTHER Pathway | Vasopressin synthesis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.